Loading…

Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development

Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return to homeostasis. However, chronic inflammation induces permanent changes in cytokine production which exacerbate tissue damage and m...

Full description

Saved in:
Bibliographic Details
Published in:iScience 2022-02, Vol.25 (2), p.103790-103790, Article 103790
Main Authors: Sibilio, Annarita, Suñer, Clara, Fernández-Alfara, Marcos, Martín, Judit, Berenguer, Antonio, Calon, Alexandre, Chanes, Veronica, Millanes-Romero, Alba, Fernández-Miranda, Gonzalo, Batlle, Eduard, Fernández, Mercedes, Méndez, Raúl
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83
cites cdi_FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83
container_end_page 103790
container_issue 2
container_start_page 103790
container_title iScience
container_volume 25
creator Sibilio, Annarita
Suñer, Clara
Fernández-Alfara, Marcos
Martín, Judit
Berenguer, Antonio
Calon, Alexandre
Chanes, Veronica
Millanes-Romero, Alba
Fernández-Miranda, Gonzalo
Batlle, Eduard
Fernández, Mercedes
Méndez, Raúl
description Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return to homeostasis. However, chronic inflammation induces permanent changes in cytokine production which exacerbate tissue damage and may even favor tumor development. Here, we address the contribution of post-transcriptional regulation, by the RNA-binding protein CPEB4, to intestinal immune homeostasis and its role in inflammatory bowel diseases (IBD) and colorectal cancer (CRC) development. We found that intestinal damage induces CPEB4 expression in adaptive and innate immune cells, which is required for the translation of cytokine mRNA(s) such as the one encoding interleukin-22. Accordingly, CPEB4 is required for the development of gut-associated lymphoid tissues and to maintain intestinal immune homeostasis, mediating repair and remodeling after acute inflammatory tissue damage and promoting the resolution of intestinal inflammation. CPEB4 is chronically overexpressed in inflammatory cells in patients with IBD and in CRC, favoring tumor development. [Display omitted] •CPEB4 is overexpressed in Th17 and ILC3 cells upon intestinal barrier damage•CPEB4 is required for Il-22 mRNA translation and IL-22 expression•CPEB4 promotes tissue repair in acute transient inflammation•In chronic inflammation CPEB4 exacerbates intestinal pathology and promotes tumor growth Biological sciences; Molecular biology; Immunology
doi_str_mv 10.1016/j.isci.2022.103790
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5d1b1d835f004fd4b8a76527e425c41e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589004222000608</els_id><doaj_id>oai_doaj_org_article_5d1b1d835f004fd4b8a76527e425c41e</doaj_id><sourcerecordid>2636147554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhhtR3GXdP-BB-uhlxnx2d0AEHVYdWNCDnkM6XRkzpJMx6R7Yf7_VM-uyexFCUlS99SSpt6reUrKmhDYf9mtfrF8zwhgmeKvIi-qSyU6tCBHs5ZP4orouZU8IYbiEal5XF1wywRnll9W0Hcc5Qj1lE0swk0_RhNqmOOUU6v6u3vy8-SLqDLsZq1BqH3Gf_KLy0QUzjqcmVJQU5lNo4oCEkDLYaYGZaCHXAxwhpMMIcXpTvXImFLh-OK-q319vfm2-r25_fNtuPt-urGR0WnE52NY55UhDnGxlayhplRVgnaFdL40Ax63iHGinGqNEz50E1itKXStdx6-q7Zk7JLPXh-xHk-90Ml6fEinvtMmTtwG0HGhPh45LhyNzg-g70zaStSCYtIICsj6dWYe5H2Gw-I1swjPo80r0f_QuHXXXSYUgBLx_AOT0d8YZ6hEdhBBMhDQXzRreUNFKKVDKzlKbUykZ3OM1lOjFfb3Xi_t6cV-f3cemd08f-Njyz2sUfDwLAEd-9JA1IgC9GfziFM7E_49_D1Upw4s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2636147554</pqid></control><display><type>article</type><title>Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development</title><source>PubMed (Medline)</source><source>ScienceDirect Journals</source><creator>Sibilio, Annarita ; Suñer, Clara ; Fernández-Alfara, Marcos ; Martín, Judit ; Berenguer, Antonio ; Calon, Alexandre ; Chanes, Veronica ; Millanes-Romero, Alba ; Fernández-Miranda, Gonzalo ; Batlle, Eduard ; Fernández, Mercedes ; Méndez, Raúl</creator><creatorcontrib>Sibilio, Annarita ; Suñer, Clara ; Fernández-Alfara, Marcos ; Martín, Judit ; Berenguer, Antonio ; Calon, Alexandre ; Chanes, Veronica ; Millanes-Romero, Alba ; Fernández-Miranda, Gonzalo ; Batlle, Eduard ; Fernández, Mercedes ; Méndez, Raúl</creatorcontrib><description>Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return to homeostasis. However, chronic inflammation induces permanent changes in cytokine production which exacerbate tissue damage and may even favor tumor development. Here, we address the contribution of post-transcriptional regulation, by the RNA-binding protein CPEB4, to intestinal immune homeostasis and its role in inflammatory bowel diseases (IBD) and colorectal cancer (CRC) development. We found that intestinal damage induces CPEB4 expression in adaptive and innate immune cells, which is required for the translation of cytokine mRNA(s) such as the one encoding interleukin-22. Accordingly, CPEB4 is required for the development of gut-associated lymphoid tissues and to maintain intestinal immune homeostasis, mediating repair and remodeling after acute inflammatory tissue damage and promoting the resolution of intestinal inflammation. CPEB4 is chronically overexpressed in inflammatory cells in patients with IBD and in CRC, favoring tumor development. [Display omitted] •CPEB4 is overexpressed in Th17 and ILC3 cells upon intestinal barrier damage•CPEB4 is required for Il-22 mRNA translation and IL-22 expression•CPEB4 promotes tissue repair in acute transient inflammation•In chronic inflammation CPEB4 exacerbates intestinal pathology and promotes tumor growth Biological sciences; Molecular biology; Immunology</description><identifier>ISSN: 2589-0042</identifier><identifier>EISSN: 2589-0042</identifier><identifier>DOI: 10.1016/j.isci.2022.103790</identifier><identifier>PMID: 35243213</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biological sciences ; Immunology ; Molecular biology</subject><ispartof>iScience, 2022-02, Vol.25 (2), p.103790-103790, Article 103790</ispartof><rights>2022 The Author(s)</rights><rights>2022 The Author(s).</rights><rights>2022 The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83</citedby><cites>FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859527/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2589004222000608$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35243213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sibilio, Annarita</creatorcontrib><creatorcontrib>Suñer, Clara</creatorcontrib><creatorcontrib>Fernández-Alfara, Marcos</creatorcontrib><creatorcontrib>Martín, Judit</creatorcontrib><creatorcontrib>Berenguer, Antonio</creatorcontrib><creatorcontrib>Calon, Alexandre</creatorcontrib><creatorcontrib>Chanes, Veronica</creatorcontrib><creatorcontrib>Millanes-Romero, Alba</creatorcontrib><creatorcontrib>Fernández-Miranda, Gonzalo</creatorcontrib><creatorcontrib>Batlle, Eduard</creatorcontrib><creatorcontrib>Fernández, Mercedes</creatorcontrib><creatorcontrib>Méndez, Raúl</creatorcontrib><title>Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development</title><title>iScience</title><addtitle>iScience</addtitle><description>Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return to homeostasis. However, chronic inflammation induces permanent changes in cytokine production which exacerbate tissue damage and may even favor tumor development. Here, we address the contribution of post-transcriptional regulation, by the RNA-binding protein CPEB4, to intestinal immune homeostasis and its role in inflammatory bowel diseases (IBD) and colorectal cancer (CRC) development. We found that intestinal damage induces CPEB4 expression in adaptive and innate immune cells, which is required for the translation of cytokine mRNA(s) such as the one encoding interleukin-22. Accordingly, CPEB4 is required for the development of gut-associated lymphoid tissues and to maintain intestinal immune homeostasis, mediating repair and remodeling after acute inflammatory tissue damage and promoting the resolution of intestinal inflammation. CPEB4 is chronically overexpressed in inflammatory cells in patients with IBD and in CRC, favoring tumor development. [Display omitted] •CPEB4 is overexpressed in Th17 and ILC3 cells upon intestinal barrier damage•CPEB4 is required for Il-22 mRNA translation and IL-22 expression•CPEB4 promotes tissue repair in acute transient inflammation•In chronic inflammation CPEB4 exacerbates intestinal pathology and promotes tumor growth Biological sciences; Molecular biology; Immunology</description><subject>Biological sciences</subject><subject>Immunology</subject><subject>Molecular biology</subject><issn>2589-0042</issn><issn>2589-0042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kU2LFDEQhhtR3GXdP-BB-uhlxnx2d0AEHVYdWNCDnkM6XRkzpJMx6R7Yf7_VM-uyexFCUlS99SSpt6reUrKmhDYf9mtfrF8zwhgmeKvIi-qSyU6tCBHs5ZP4orouZU8IYbiEal5XF1wywRnll9W0Hcc5Qj1lE0swk0_RhNqmOOUU6v6u3vy8-SLqDLsZq1BqH3Gf_KLy0QUzjqcmVJQU5lNo4oCEkDLYaYGZaCHXAxwhpMMIcXpTvXImFLh-OK-q319vfm2-r25_fNtuPt-urGR0WnE52NY55UhDnGxlayhplRVgnaFdL40Ax63iHGinGqNEz50E1itKXStdx6-q7Zk7JLPXh-xHk-90Ml6fEinvtMmTtwG0HGhPh45LhyNzg-g70zaStSCYtIICsj6dWYe5H2Gw-I1swjPo80r0f_QuHXXXSYUgBLx_AOT0d8YZ6hEdhBBMhDQXzRreUNFKKVDKzlKbUykZ3OM1lOjFfb3Xi_t6cV-f3cemd08f-Njyz2sUfDwLAEd-9JA1IgC9GfziFM7E_49_D1Upw4s</recordid><startdate>20220218</startdate><enddate>20220218</enddate><creator>Sibilio, Annarita</creator><creator>Suñer, Clara</creator><creator>Fernández-Alfara, Marcos</creator><creator>Martín, Judit</creator><creator>Berenguer, Antonio</creator><creator>Calon, Alexandre</creator><creator>Chanes, Veronica</creator><creator>Millanes-Romero, Alba</creator><creator>Fernández-Miranda, Gonzalo</creator><creator>Batlle, Eduard</creator><creator>Fernández, Mercedes</creator><creator>Méndez, Raúl</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220218</creationdate><title>Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development</title><author>Sibilio, Annarita ; Suñer, Clara ; Fernández-Alfara, Marcos ; Martín, Judit ; Berenguer, Antonio ; Calon, Alexandre ; Chanes, Veronica ; Millanes-Romero, Alba ; Fernández-Miranda, Gonzalo ; Batlle, Eduard ; Fernández, Mercedes ; Méndez, Raúl</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biological sciences</topic><topic>Immunology</topic><topic>Molecular biology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sibilio, Annarita</creatorcontrib><creatorcontrib>Suñer, Clara</creatorcontrib><creatorcontrib>Fernández-Alfara, Marcos</creatorcontrib><creatorcontrib>Martín, Judit</creatorcontrib><creatorcontrib>Berenguer, Antonio</creatorcontrib><creatorcontrib>Calon, Alexandre</creatorcontrib><creatorcontrib>Chanes, Veronica</creatorcontrib><creatorcontrib>Millanes-Romero, Alba</creatorcontrib><creatorcontrib>Fernández-Miranda, Gonzalo</creatorcontrib><creatorcontrib>Batlle, Eduard</creatorcontrib><creatorcontrib>Fernández, Mercedes</creatorcontrib><creatorcontrib>Méndez, Raúl</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>iScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sibilio, Annarita</au><au>Suñer, Clara</au><au>Fernández-Alfara, Marcos</au><au>Martín, Judit</au><au>Berenguer, Antonio</au><au>Calon, Alexandre</au><au>Chanes, Veronica</au><au>Millanes-Romero, Alba</au><au>Fernández-Miranda, Gonzalo</au><au>Batlle, Eduard</au><au>Fernández, Mercedes</au><au>Méndez, Raúl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development</atitle><jtitle>iScience</jtitle><addtitle>iScience</addtitle><date>2022-02-18</date><risdate>2022</risdate><volume>25</volume><issue>2</issue><spage>103790</spage><epage>103790</epage><pages>103790-103790</pages><artnum>103790</artnum><issn>2589-0042</issn><eissn>2589-0042</eissn><abstract>Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return to homeostasis. However, chronic inflammation induces permanent changes in cytokine production which exacerbate tissue damage and may even favor tumor development. Here, we address the contribution of post-transcriptional regulation, by the RNA-binding protein CPEB4, to intestinal immune homeostasis and its role in inflammatory bowel diseases (IBD) and colorectal cancer (CRC) development. We found that intestinal damage induces CPEB4 expression in adaptive and innate immune cells, which is required for the translation of cytokine mRNA(s) such as the one encoding interleukin-22. Accordingly, CPEB4 is required for the development of gut-associated lymphoid tissues and to maintain intestinal immune homeostasis, mediating repair and remodeling after acute inflammatory tissue damage and promoting the resolution of intestinal inflammation. CPEB4 is chronically overexpressed in inflammatory cells in patients with IBD and in CRC, favoring tumor development. [Display omitted] •CPEB4 is overexpressed in Th17 and ILC3 cells upon intestinal barrier damage•CPEB4 is required for Il-22 mRNA translation and IL-22 expression•CPEB4 promotes tissue repair in acute transient inflammation•In chronic inflammation CPEB4 exacerbates intestinal pathology and promotes tumor growth Biological sciences; Molecular biology; Immunology</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35243213</pmid><doi>10.1016/j.isci.2022.103790</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2589-0042
ispartof iScience, 2022-02, Vol.25 (2), p.103790-103790, Article 103790
issn 2589-0042
2589-0042
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5d1b1d835f004fd4b8a76527e425c41e
source PubMed (Medline); ScienceDirect Journals
subjects Biological sciences
Immunology
Molecular biology
title Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A19%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20translational%20control%20by%20CPEB4%20regulates%20intestinal%20inflammation%20resolution%20and%20colorectal%20cancer%20development&rft.jtitle=iScience&rft.au=Sibilio,%20Annarita&rft.date=2022-02-18&rft.volume=25&rft.issue=2&rft.spage=103790&rft.epage=103790&rft.pages=103790-103790&rft.artnum=103790&rft.issn=2589-0042&rft.eissn=2589-0042&rft_id=info:doi/10.1016/j.isci.2022.103790&rft_dat=%3Cproquest_doaj_%3E2636147554%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-35dc7ff9f060f5757a1079c4ecfa18b5a4ef3c933e1896a94b3f5e2b911f75f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2636147554&rft_id=info:pmid/35243213&rfr_iscdi=true